Xingfu Bao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Xingfu Bao has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Guanghong Han
Hospital of Stomatology, Jilin University
2 shared publications - Min Hu
Hospital of Stomatology, Jilin University, Changchun 130021, China
2 shared publications - Yuyan Liu
Department of Endodontics, School of Stomatology, Jilin University, Changchun 130021, China
2 shared publications - Zhigang Zuo
Department of Orthodontics, School of Stomatology, Tianjin Medical University, Tianjin 300014, China
2 shared publications
Latest Publications
- Open Access
- 24 May 2019
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 20 (10) , 2562
Xingfu Bao et al. The Effect on Proliferation and Differentiation of Cementoblast by Using Sclerostin as Inhibitor. Int. J. Mol. Sci. 2013, 14, 21140
The authors wish to make the following correction to this paper
- 24 May 2019
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 20 (10) , 2562
Open AccessXingfu Bao et al. The Effect on Proliferation and Differentiation of Cementoblast by Using Sclerostin as Inhibitor. Int. J. Mol. Sci. 2013, 14, 21140
The authors wish to make the following correction to this paper
- Open Access
- 21 October 2013
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 14 (10) , 21140-21152
The Effect on Proliferation and Differentiation of Cementoblast by Using Sclerostin as Inhibitor
Cementogenesis is of great importance for normal teeth root development and is involved in the repair process of root resorption caused by orthodontic treatment. As highly differentiated mesenchymal cells, cementoblasts are responsible for this process under the regulation of many endogenous agents. Among these molecules, sclerostin has been much investigated recently for its distinct antagonism effect on bone metabolism. Encoded by the sost gene, sclerostin is expressed in osteocytes and cementocytes of cellular cementum. it is still unclear. In the current study, we investigated the effects of sclerostin on the processes of proliferation and differentiation; a series of experiments including MTT, apoptosis examination, alkaline phosphatase (ALP) activity, gene analysis, and alizarin red staining were carried out to evaluate the proliferation and differentiation of cementoblasts. Protein expression including osteoprotegerin (OPG) and receptor activator of nuclear factor kappa B ligand (RANKL) were also checked to analyze changes in osteoclastogenesis. Results show that sclerostin inhibits cementoblasts proliferation and differentiation, and promotes osteoclastogenesis. Interestingly, the monoclonal antibody for sclerostin has shown positive effects on osteoporosis, indicating that it may facilitate cementogenesis and benefit the treatment of cementum related diseases.
- 21 October 2013
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 14 (10) , 21140-21152
Open AccessThe Effect on Proliferation and Differentiation of Cementoblast by Using Sclerostin as Inhibitor
Cementogenesis is of great importance for normal teeth root development and is involved in the repair process of root resorption caused by orthodontic treatment. As highly differentiated mesenchymal cells, cementoblasts are responsible for this process under the regulation of many endogenous agents. Among these molecules, sclerostin has been much investigated recently for its distinct antagonism effect on bone metabolism. Encoded by the sost gene, sclerostin is expressed in osteocytes and cementocytes of cellular cementum. it is still unclear. In the current study, we investigated the effects of sclerostin on the processes of proliferation and differentiation; a series of experiments including MTT, apoptosis examination, alkaline phosphatase (ALP) activity, gene analysis, and alizarin red staining were carried out to evaluate the proliferation and differentiation of cementoblasts. Protein expression including osteoprotegerin (OPG) and receptor activator of nuclear factor kappa B ligand (RANKL) were also checked to analyze changes in osteoclastogenesis. Results show that sclerostin inhibits cementoblasts proliferation and differentiation, and promotes osteoclastogenesis. Interestingly, the monoclonal antibody for sclerostin has shown positive effects on osteoporosis, indicating that it may facilitate cementogenesis and benefit the treatment of cementum related diseases.